Quantcast

Latest Omeros Corporation Stories

2014-12-15 12:26:37

DALLAS, December 15, 2014 /PRNewswire/ -- ReportsnReports.com adds Ocular Disorders: Rising Therapeutics, Technologies, and Devices 2014 market research report that covers

2014-11-19 08:27:47

- Data Bode Well for Success of Ongoing Phase 2 Trial in Thrombotic Microangiopathies - SEATTLE, Nov.

2014-11-10 16:31:48

-- Omidria(TM) U.S. Commercial Launch Planned for Early 2015 -- SEATTLE, Nov.

2014-10-30 08:35:10

-- Unique Billing Code Allows Separate Payment for Omidria -- SEATTLE, Oct.

2014-10-21 08:33:06

-- Enrollment in Huntington's Trial Suspended Pending Further Assessment of Preclinical Data -- SEATTLE, Oct.

2014-08-11 16:28:03

-- FDA Approval of Omidria(TM) Received on May 30, 2014 - SEATTLE, Aug.


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related